KFF Health News

‘I’m Not Safe Here’: Schools Ignore Federal Rules on Restraint and Seclusion

How History Has Shaped Racial and Ethnic Health Disparities

Black Women Often Misdiagnosed with Diabetes

RFK Jr.’s Campaign of Conspiracy Theories Is PolitiFact’s 2023 Lie of the Year

Deep Flaws in FDA Oversight of Medical Devices, and Patient Harm, Exposed in Lawsuits and Records

Why the CDC Has Recommended New Covid Boosters for All

Being Black and Pregnant in the Deep South Can Be a Dangerous Combination

Why the next big hope for Alzheimer’s might not help most Black patients

This week the FDA is expected to approve what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see it as the unfortunate triumph of a flawed theory of the disease’s cause and predict the rollout of the drug will aggravate racial disparities in elder care.

Advocates call for 911 changes. Police have mixed feelings.

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?